Researchers retract controversial study on hydroxychloroquine that poses a great risk

Hydroxychloroquine is found to be useful in treating autoimmune diseases like lupus and also for rheumatoid arthritis. It is now being studied for use in COVID-19 patients. Even President of the United States touted it as a game-changer in current practice to prevent the infection. But the report from The Lancet and The New England Journal of Medicine showed that the drug that taken either alone or with an antibiotic to treat patients with COVID-19 was of no benefit and increased a patient’s risk of cardiac death.

The study

The study published in The Lancet involved almost 96,000 coronavirus patients across 671 hospitals all over the world. Doctors administered hydroxychloroquine or its related drugs with or without antibiotics to nearly 15,000 patients. They found that the patients were more likely to develop heart rhythm complications leading to death. The death rate of patients treated with hydroxychloroquine was 18%, and those treated with chloroquine were 26.4%. These findings have influenced many countries to ban the use of hydroxychloroquine and also halts the ongoing drug trials of the World Health Organization (WHO); however, they have started it again from June 3.

- Advertisement -

Read Also: Dynamics of glass-forming liquid revealed in new study

The New England Journal of Medicine study also analyzed 8,910 COVID-19 patients and found that the drugs failed to prevent coronavirus symptoms and also increases cardiac risk.

Retraction of the findings

The authors of these studies retracted their findings because independent auditors weren’t able to access all the information needed to verify the data. The whole data was collected by a private company called Surgisphere, a Chicago based company whose founder named Sapan Desai. The study published in Lancet attracted criticism from various scientists, and hence it required Surgisphere to transfer their database for evaluation. Surgisphere agreed to review, but the third party reviewers said the Lancet that they were not able to access all the data because it might violent client agreements and confidentiality requirements. It was this failure that made the authors retract the paper.

Read Also: Another major Windows 10 update: Enhancements and security features

- Advertisement -

Anyways, it was not only the study that tells about the adverse effects of hydroxychloroquine. Researchers from the University of Minnesota also declares the ineffectiveness of the drug against coronavirus after undergoing some clinical trial. The FDA also said that the drug should only be used in a clinical trial under careful medical supervision with emergency authorization. As the Lancet study was withdrawn, it won’t create much change in the research because other study findings proved the same concept consistently.

Do you want to publish on Apple News, Google News, and more? Join our writing community, improve your writing skills, and be read by hundreds of thousands around the world!

Source: CBS

Related Stories

Mutated coronavirus strain now dominates, scientists say

While the first wave of the pandemic was wreaking havoc to the whole world, scientists worry about...

New anticancer substance discovered while searching for COVID-19 medicine

Researchers from the North Caucasus Federal University (NCFU), along with their US counterparts, have discovered a new...

Featured Stories

Venus: 10 shocking facts about our nearest planet you never knew

1. A day on Venus is longer than its year. It takes 243 Earth...

How to deal with COVID-19? A Zumba® Ambassador reveals the secret!

Keeping our mental and physical health in this difficult time has been, and it still is a...

Search for alien life among 10 million star systems ends with no results

A search for alien life in other star systems has come up empty-handed. A recent project named...

The post-inflammatory syndrome of COVID-19 is becoming more complex in children

After contracting the COVID-19 and recovery, the body takes its own time to get to normal. Unfortunately,...

FDA authorizes Abbott’s 15-minute, $5 COVID-19 card test ‘BinaxNOW’

Abbott Laboratories’ new technology might change the game in how the spread of the COVID-19 pandemic is...

The new Fitbit Sense will detect how stressed you are

In the past, Versa has been the flagship for the Fitbit company, but no more for Fitbit...

Comment Below

Mutated coronavirus strain now dominates, scientists say

While the first wave of the pandemic was wreaking havoc to the whole world, scientists worry about...

New anticancer substance discovered while searching for COVID-19 medicine

Researchers from the North Caucasus Federal University (NCFU), along with their US counterparts, have discovered a new...